It is the first study to document how PFCs, which can be transferred to children prenatally (via the mother) and postnatally from exposure in the environment, can adversely affect vaccine response.
The study appears in the January 25, 2012 issue of the Journal of the American Medical Association (JAMA). Read a background memo on the findings.
“Routine childhood immunizations are a mainstay of modern disease prevention. The negative impact on childhood vaccinations from PFCs should be viewed as a potential threat to public health,” said study lead author Philippe Grandjean, adjunct professor of environmental health at Harvard School of Public Health.
PFCs have thousands of industrial and manufacturing uses. Most Americans have the chemical compounds in their bodies. Prior studies have shown that PFC concentrations in mice similar to those found in people suppressed immune response, but the adverse effects on people had been poorly documented.
The researchers analyzed data on children recruited at birth at National Hospital in Torshavn, Faroe Islands during 1999-2001. A total of 587 participated in follow-up examinations. Children were tested for immune response to tetanus and diphtheria vaccinations at ages 5 and 7 years. PFCs were measured in maternal pregnancy serum and in the serum of children at age 5 to determine prenatal and postnatal exposure.
The results showed that PFC exposure was associated with lower antibody responses to immunizations and an increased risk of antibody levels in children lower than those needed to provide long-term protection. (Antibody concentrations in serum are a good indicator of overall immune functions in children.) A two-fold greater concentration of three major PFCs was associated with a 49% lower level of serum antibodies in children at age 7 years.
“We were surprised by the steep negative associations, which suggest that PFCs may be more toxic to the immune system than current dioxin exposures,” said Grandjean.
The PFC concentrations are similar to or slightly below those reported in U.S. women, and most serum PFC levels in Faroese children at age 5 were lower than those measured in U.S. children aged 3 to 5 years in 2001-2002.
This study was supported by the National Institute of Environmental Health Sciences (part of the National Institutes of Health), the U.S. Environmental Protection Agency, the Danish Council for Strategic Research, and the Danish Environmental Protection Agency.
“Serum Vaccine Antibody Concentrations in Children Exposed to Perfluorinated Compounds,” Philippe Grandjean, Elisabeth Wreford Andersen, Esben Budtz-Jorgensen, Flemming Nielsen, Kare Molbak, Pal Weihe, Carsten Heilmann, JAMA, January 25, 2012, Vol. 307, No. 4, pp. 391-397
For more information:
Harvard School of Public Health is dedicated to advancing the public’s health through learning, discovery and communication. More than 400 faculty members are engaged in teaching and training the 1,000-plus student body in a broad spectrum of disciplines crucial to the health and well being of individuals and populations around the world. Programs and projects range from the molecular biology of AIDS vaccines to the epidemiology of cancer; from risk analysis to violence prevention; from maternal and children’s health to quality of care measurement; from health care management to international health and human rights. For more information on the school visit www.hsph.harvard.edu.